Roche is in discussions with HHS to launch a direct-to-patient drug distribution model.  CEO Thomas Schinecker said the move is being considered as a way to reduce prices for patients, pointing to the role of pharmacy benefit managers, saying they…

The FDA is investigating the death of an 8-year-old boy who received Elevidys, a gene therapy developed by Sarepta Therapeutics to treat Duchenne muscular dystrophy.  The child died June 7, prompting the FDA to request a voluntary suspension of the…

After months of negotiations and temporary extensions, President Donald Trump’s global tariff policy is set to take effect Aug. 1. The administration has finalized agreements with several countries, including Japan and the United Kingdom, and the European Union, setting tariff…

Allison Riffle, PharmD, executive director and associate chief of pharmacy at Cleveland Clinic, is stepping down from her role after over a decade with the health system.  “It’s hard to express the amount of gratitude and pride I have for…

Boise, Idaho-based St. Luke’s Health System has opened a 330,000-square-foot Consolidated Service Center in Meridian, Idaho, with the goal of streamlining its supply chain and expanding pharmacy functions.  The facility houses 20,000 storage bins and 6,000 medical and nonmedical supplies…

Roche has halted some international shipments of the gene therapy Elevidys, used to treat Duchenne muscular dystrophy, Bloomberg reported July 22.  The decision comes in the wake of a similar move by Sarepta Therapeutics, which developed the drug. The drugmaker…

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at the Becker’s Healthcare Fall Chief Pharmacy Officer…

A federal judge has temporarily blocked portions of Iowa’s pharmacy benefit manager law, Senate File 383, ruling that several provisions likely conflict with federal law, the Des Moines Register reported July 22.  Here are three notes: 

Lawmakers in the House and Senate introduced legislation this week that could prohibit pharmaceutical companies from restricting access to 340B drug pricing discounts.  The Pharmaceutical Access to Invest in Essential, Needed Treatments & Support Act, introduced by Rep. Doris Matsui…

After reaching a record high in 2024, the number of active drug shortages is declining, according to a recent American Society of Health-System Pharmacists report. However, while new shortages have slowed, many hospitals and health systems continue to face challenges…